|
[1]
|
Sung, H., Ferlay, J., Siegel, R.L., et al. (2021) Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA: A Cancer Journal for Clinicians, 71, 209-249. [Google Scholar] [CrossRef] [PubMed]
|
|
[2]
|
European Association for the Study of the Liver and European Organisation for Research and Treatment of Cancer (2012) EASL-EORTC Clinical Practice Guidelines: Management of Hepatocellular Carcinoma. Journal of Hepatology, 56, 908-943. [Google Scholar] [CrossRef] [PubMed]
|
|
[3]
|
Galle, P.R., Forner, A., Llovet, J.M., et al. (2018) EASL Clinical Practice Guidelines: Management of Hepatocellular Carcinoma. Journal of Hepatology, 69, 182-236. [Google Scholar] [CrossRef] [PubMed]
|
|
[4]
|
Kennedy, J.E., Wu, F., Ter, Haar, G.R., et al. (2004) High-Intensity Focused Ultrasound for the Treatment of Liver Tumours. Ultrasonics, 42, 931-935. [Google Scholar] [CrossRef] [PubMed]
|
|
[5]
|
Cheung, T.T., Fan, S.T., Chan, S.C., et al. (2013) High-Intensity Focused Ultrasound Ablation: An Effective Bridging Therapy for Hepatocellular Carcinoma Patients. World Journal of Gastroenterology, 19, 3083-3089. [Google Scholar] [CrossRef] [PubMed]
|
|
[6]
|
Cheung, T.T., Poon, R.T., Jenkins, C.R., et al. (2014) Survival Analysis of High-Intensity Focused Ultrasound Therapy vs. Transarterial Chemoembolization for Unresectable Hepatocellular Carcinomas. Liver International, 34, e136-e143. [Google Scholar] [CrossRef] [PubMed]
|
|
[7]
|
Ji, Y., Zhu, J., Zhu, L., et al. (2020) High-Intensity Focused Ultrasound Ablation for Unresectable Primary and Metastatic Liver Cancer: Real-World Research in a Chinese Tertiary Center with 275 Cases. Frontiers in Oncology, 10, Article 519164. [Google Scholar] [CrossRef] [PubMed]
|
|
[8]
|
Schraml, C., Kaufmann, S., Rempp, H., et al. (2015) Imaging of HCC-Current State of the Art. Diagnostics, 5, 513-545. [Google Scholar] [CrossRef] [PubMed]
|
|
[9]
|
(2009) Pathologic Diagnosis of Early Hepatocellular Carcinoma: A Report of the International Consensus Group for Hepatocellular Neoplasia. Hepatology, 49, 658-664. [Google Scholar] [CrossRef] [PubMed]
|
|
[10]
|
Forner, A., Reig, M., Bruix, J. (2018) Hepatocellular Carcinoma. Lancet, 391, 1301-1314. [Google Scholar] [CrossRef]
|
|
[11]
|
Ahn, J.C., Teng, P.C., Chen, P.J., et al. (2021) Detection of Circulating Tumor Cells and Their Implications as a Biomarker for Diagnosis, Prognostication, and Therapeutic Monitoring in Hepatocellular Carcinoma. Hepatology, 73, 422-436. [Google Scholar] [CrossRef] [PubMed]
|
|
[12]
|
Harris, P.S., Hansen, R.M., Gray, M.E., et al. (2019) Hepatocellular Carcinoma Surveillance: An Evidence-Based Approach. World Journal of Gastroenterology, 25, 1550-1559. [Google Scholar] [CrossRef] [PubMed]
|
|
[13]
|
Trevisani, F., D’Intino, P.E., Morselli-Labate, A.M., et al. (2001) Serum α-Fetoprotein for Diagnosis of Hepatocellular Carcinoma in Patients with Chronic Liver Disease: Influence of HBsAg and Anti-HCV Status. Journal of Hepatology, 34, 570-575. [Google Scholar] [CrossRef]
|
|
[14]
|
Vaidyanathan, R., Soon, R.H., Zhang, P., et al. (2018) Cancer Diagnosis: From Tumor to Liquid Biopsy and Beyond. Lab on a Chip, 19, 11-34. [Google Scholar] [CrossRef]
|
|
[15]
|
Yu, W., Hurley, J., Roberts, D., et al. (2021) Exosome-Based Liquid Biopsies in Cancer: Opportunities and Challenges. Annals of Oncology, 32, 466-477. [Google Scholar] [CrossRef] [PubMed]
|
|
[16]
|
Cai, X., Janku, F., Zhan, Q., et al. (2015) Accessing Genetic Information with Liquid Biopsies. Trends in Genetics, 31, 564-575. [Google Scholar] [CrossRef] [PubMed]
|
|
[17]
|
Zhu, Z., Wang, H., Pang, Y., et al. (2020) Exosomal Long Non-Coding RNA UCA1 Functions as Growth Inhibitor in Esophageal Cancer. Aging, 12, 20523-20539. [Google Scholar] [CrossRef] [PubMed]
|
|
[18]
|
Xu, M.L., Liu, T.C., Dong, F.X., et al. (2021) Exosomal LncRNA LINC01711 Facilitates Metastasis of Esophageal Squamous Cell Carcinoma via the MiR-326/FSCN1 Axis. Aging, 13, 19776-19788. [Google Scholar] [CrossRef] [PubMed]
|
|
[19]
|
Li, Z., Ma, L., Di, L., et al. (2021) MicroRNA‑1271‑5p Alleviates the Malignant Development of Hepatitis B Virus‑Mediated Liver Cancer via Binding to AQP5. Molecular Medicine Reports, 23, Article No. 386. [Google Scholar] [CrossRef] [PubMed]
|
|
[20]
|
Cao, C. and Wang, C. (2020) Clinical Significance of Serum MiR-768-3p in HBV-Related Hepatocellular Carcinoma and Its Potential Mechanism. Clinical and Experimental Medicine, 20, 569-576. [Google Scholar] [CrossRef] [PubMed]
|
|
[21]
|
Cao, X., Yang, Q., Yu, Q. (2020) Increased Expression of MiR-487b Is Associated with Poor Prognosis and Tumor Progression of HBV-Related Hepatocellular Carcinoma. Open Forum Infectious Diseases, 7, ofaa498. [Google Scholar] [CrossRef] [PubMed]
|
|
[22]
|
Morishita, A., Fujita, K., Iwama, H., et al. (2020) Role of MicroRNA-210-3p in Hepatitis B Virus-Related Hepatocellular Carcinoma. American Journal of Physiology-Gastrointestinal and Liver Physiology, 318, G401-G409. [Google Scholar] [CrossRef] [PubMed]
|
|
[23]
|
Zhao, L., Yang, Q. and Liu, J. (2021) Clinical Value Evaluation of MicroRNA-324-3p and Other Available Biomarkers in Patients with HBV Infection-Related Hepatocellular Carcinoma. Open Forum Infectious Diseases, 8, ofab108. [Google Scholar] [CrossRef] [PubMed]
|
|
[24]
|
Li, X., Guo, Y., Wang, X., et al. (2021) Clinical Significance of Serum MiR-487b in HBV-Related Hepatocellular Carcinoma and Its Potential Mechanism. Infectious Diseases, 53, 546-554. [Google Scholar] [CrossRef] [PubMed]
|
|
[25]
|
Chen, W., Jiang, J., Gong, L., et al. (2021) Hepatitis B Virus P Protein Initiates Glycolytic Bypass in HBV-Related Hepatocellular Carcinoma via A FOXO3/MiRNA-30b-5p/MINPP1 Axis. Journal of Experimental & Clinical Cancer Research, 40, Article No. 1. [Google Scholar] [CrossRef] [PubMed]
|
|
[26]
|
Sun, Y., Shi, P., Wu, Q., et al. (2021) MiR-222-3p Induced by Hepatitis B Virus Promotes the Proliferation and Inhibits Apoptosis in Hepatocellular Carcinoma by Upregulating THBS1. Human Cell, 34, 1788-1799. [Google Scholar] [CrossRef] [PubMed]
|
|
[27]
|
Zhou, G., Zeng, Y., Luo, Y., et al. (2022) Urine MiR-93-5p Is a Promising Biomarker for Early Detection of HBV-Related Hepatocellular Carcinoma. European Journal of Surgical Oncology, 48, 95-102. [Google Scholar] [CrossRef] [PubMed]
|
|
[28]
|
Liu, Y., Wang, J., Chen, J., et al. (2022) Upregulation of MiR-520c-3p via Hepatitis B Virus Drives Hepatocellular Migration and Invasion by the PTEN/AKT/NF-κB Axis. Nucleic Acids, 29, 47-63. [Google Scholar] [CrossRef] [PubMed]
|
|
[29]
|
Yu, G., Mu, H., Zhou, H., et al. (2021) MicroRNA-361 Suppresses the Biological Processes of Hepatic Stellate Cells in HBV-Relative Hepatic Fibrosis by NF-κB P65. Cells & Development, 167, Article ID: 203711. [Google Scholar] [CrossRef] [PubMed]
|
|
[30]
|
Dai, X., Huang, R., Hu, S., et al. (2020) A Novel MiR-0308-3p Revealed by MiRNA-Seq of HBV-Positive Hepatocellular Carcinoma Suppresses Cell Proliferation and Promotes G1/S Arrest by Targeting Double CDK6/Cyclin D1 Genes. Cell & Bioscience, 10, Article No. 24. [Google Scholar] [CrossRef] [PubMed]
|
|
[31]
|
Wang, C., Su, K., Lin, H., et al. (2022) Identification and Verification of a Novel MAGI2-AS3/MiRNA-374-5p/FOXO1 Network Associated with HBV-Related HCC. Cells, 11, Article 3466. [Google Scholar] [CrossRef] [PubMed]
|
|
[32]
|
Wei, X.C., Xia, Y.R., Zhou, P., et al. (2021) Hepatitis B Core Antigen Modulates Exosomal MiR-135a to Target Vesicle-Associated Membrane Protein 2 Promoting Chemoresistance in Hepatocellular Carcinoma. World Journal of Gastroenterology, 27, 8302-8322. [Google Scholar] [CrossRef] [PubMed]
|
|
[33]
|
Qin, Y.F., Zhou, Z.Y., Fu, H.W., et al. (2023) Hepatitis B Virus Surface Antigen Promotes Stemness of Hepatocellular Carcinoma through Regulating MicroRNA-203a. Journal of Clinical and Translational Hepatology, 11, 118-129.
|
|
[34]
|
Chen, H., Cao, D., Han, N., et al. (2023) Hepatitis B Virus-Encoded MicroRNA (HBV-MiR-3) Inhibits FIH-1 Expression to Promote Tumor Angiogenesis in HBV-Related Hepatocellular Carcinoma. Journal of Hepatocellular Carcinoma, 10, 2337-2353. [Google Scholar] [CrossRef]
|
|
[35]
|
Zhang, C., Liu, P. and Zhang, C. (2020) Hepatitis B Virus X Protein Upregulates Alpha-Fetoprotein to Promote Hepatocellular Carcinoma by Targeting MiR-1236 and MiR-329. Journal of Cellular Biochemistry, 121, 2489-2499. [Google Scholar] [CrossRef] [PubMed]
|
|
[36]
|
Niu, L.J., Huang, T., Wang, L., et al. (2022) HBX Suppresses PTEN to Promote the Malignant Progression of Hepatocellular Carcinoma through Mi-R155 Activation. Annals of Hepatology, 27, Article ID: 100688. [Google Scholar] [CrossRef] [PubMed]
|
|
[37]
|
Deng, Y., Wang, L., Zhang, Y., et al. (2023) HBx Promotes Hepatocellular Carcinoma Progression by Repressing the Transcription Level of MiR-187-5p. Aging, 15, 7533-7550. [Google Scholar] [CrossRef] [PubMed]
|
|
[38]
|
Mani, S., Yan, B., Cui, Z., et al. (2020) Restoration of RNA Helicase DDX5 Suppresses Hepatitis B Virus (HBV) Biosynthesis and Wnt Signaling in HBV-Related Hepatocellular Carcinoma. Theranostics, 10, 10957-10972. [Google Scholar] [CrossRef] [PubMed]
|
|
[39]
|
Wang, J., Zhang, X., Han, J., et al. (2023) MicroRNA-124 Expression in Kupffer Cells Modulates Liver Injury by Targeting IL-6/STAT3 Signaling. Antiviral Research, 211, Article ID: 105510. [Google Scholar] [CrossRef] [PubMed]
|
|
[40]
|
Zhao, X., Sun, L., Mu, T., et al. (2020) An HBV-Encoded MiRNA Activates Innate Immunity to Restrict HBV Replication. Journal of Molecular Cell Biology, 12, 263-276. [Google Scholar] [CrossRef] [PubMed]
|
|
[41]
|
Tang, J., Xiao, X., Jiang, Y., et al. (2020) MiR-3 Encoded by Hepatitis B Virus Downregulates PTEN Protein Expression and Promotes Cell Proliferation. Journal of Hepatocellular Carcinoma, 7, 257-269. [Google Scholar] [CrossRef]
|
|
[42]
|
Ma, S., Qin, K., Ouyang, H., et al. (2020) HBV Infection Exacerbates PTEN Defects in Hepatocellular Carcinoma through Upregulation of MiR-181a/382/362/19a. American Journal of Translational Research, 12, 3780-3791.
|
|
[43]
|
Lou, W., Liu, J., Ding, B., et al. (2019) Identification of Potential MiRNA-MRNA Regulatory Network Contributing to Pathogenesis of HBV-Related HCC. Journal of Translational Medicine, 17, Article No. 7. [Google Scholar] [CrossRef] [PubMed]
|
|
[44]
|
Huang, D.P., Zeng, Y.H., Yuan, W.Q., et al. (2021) Bioinformatics Analyses of Potential MiRNA-MRNA Regulatory Axis in HBV-Related Hepatocellular Carcinoma. International Journal of Medical Sciences, 18, 335-346. [Google Scholar] [CrossRef] [PubMed]
|
|
[45]
|
Zhou, J., Yu, L., Gao, X., et al. (2011) Plasma MicroRNA Panel to Diagnose Hepatitis B Virus-Related Hepatocellular Carcinoma. Journal of Clinical Oncology, 29, 4781-4788. [Google Scholar] [CrossRef]
|
|
[46]
|
Cheng, L., Zhang, Z., Zuo, D., et al. (2018) Ultrasensitive Detection of Serum MicroRNA Using Branched DNA-Based SERS Platform Combining Simultaneous Detection of α-Fetoprotein for Early Diagnosis of Liver Cancer. ACS Applied Materials & Interfaces, 10, 34869-34877. [Google Scholar] [CrossRef] [PubMed]
|
|
[47]
|
Zhang, S., Cheng, J., Shi, W., et al. (2020) Fabrication of a Biomimetic Nanochannel Logic Platform and Its Applications in the Intelligent Detection of MiRNA Related to Liver Cancer. Analytical Chemistry, 92, 5952-5959. [Google Scholar] [CrossRef] [PubMed]
|
|
[48]
|
Wu, J., Zhou, X., Li, P., et al. (2021) Ultrasensitive and Simultaneous SERS Detection of Multiplex MicroRNA Using Fractal Gold Nanotags for Early Diagnosis and Prognosis of Hepatocellular Carcinoma. Analytical Chemistry, 93, 8799-8809. [Google Scholar] [CrossRef] [PubMed]
|
|
[49]
|
Fan, Z., Zhao, X., Dong, Y., et al. (2022) Protein-Free, Ultrasensitive MiRNA Analysis Based on an Entropy-Driven Catalytic Reaction Switched on a Smart-Responsive DNAzyme Dual-Walker Amplification Strategy. International Journal of Biological Macromolecules, 223, 931-938. [Google Scholar] [CrossRef] [PubMed]
|
|
[50]
|
Ghosh, S., Bhowmik, S., Majumdar, S., et al. (2020) the Exosome Encapsulated MicroRNAs as Circulating Diagnostic Marker for Hepatocellular Carcinoma with Low Alpha-Fetoprotein. International Journal of Cancer, 147, 2934-2947. [Google Scholar] [CrossRef] [PubMed]
|
|
[51]
|
Eldosoky, M.A., Hammad, R., Elmadbouly, A.A., et al. (2023) Diagnostic Significance of Hsa-MiR-21-5p, Hsa-MiR-192-5p, Hsa-MiR-155-5p, Hsa-MiR-199a-5p Panel and Ratios in Hepatocellular Carcinoma on Top of Liver Cirrhosis in HCV-Infected Patients. International Journal of Molecular Sciences, 24, Article 3157. [Google Scholar] [CrossRef] [PubMed]
|
|
[52]
|
Liu, W., Zheng, L., Zhang, R., et al. (2022) Circ-ZEB1 Promotes PIK3CA Expression by Silencing MiR-199a-3p and Affects the Proliferation and Apoptosis of Hepatocellular Carcinoma. Molecular Cancer, 21, Article No. 72. [Google Scholar] [CrossRef] [PubMed]
|
|
[53]
|
Loosen, S.H., Castoldi, M., Jördens, M.S., et al. (2021) Serum Levels of Circulating MicroRNA-107 Are Elevated in Patients with Early-Stage HCC. PLOS ONE, 16, e247917. [Google Scholar] [CrossRef] [PubMed]
|
|
[54]
|
Xue, S., Lu, F., Sun, C., et al. (2021) LncRNA ZEB1-AS1 Regulates Hepatocellular Carcinoma Progression by Targeting MiR-23c. World Journal of Surgical Oncology, 19, Article No. 121. [Google Scholar] [CrossRef] [PubMed]
|
|
[55]
|
Feng, Y.S., Zhou, J.M., Sun, C.H., et al. (2021) the Diagnostic Value of MiR-21 Combined with CT in Patients with Liver Cancer. Clinical and Translational Oncology, 23, 1238-1244. [Google Scholar] [CrossRef] [PubMed]
|
|
[56]
|
He, H., Zhou, J., Cheng, F., et al. (2023) MiR-3677-3p Promotes Development and Sorafenib Resistance of Hepatitis B-Related Hepatocellular Carcinoma by Inhibiting FOXM1 Ubiquitination. Human Cell, 36, 1773-1789. [Google Scholar] [CrossRef] [PubMed]
|
|
[57]
|
Zhang, Q., Deng, X., Tang, X., et al. (2021) MicroRNA-20a Suppresses Tumor Proliferation and Metastasis in Hepatocellular Carcinoma by Directly Targeting EZH1. Frontiers in Oncology, 11, Article 737986. [Google Scholar] [CrossRef] [PubMed]
|
|
[58]
|
Li, J., Zhong, X., Wang, X., et al. (2021) MiR-93 Regulates Liver Tumor Initiating Cells Expansion and Predicts Chemotherapeutic Response of Patients. Archives of Biochemistry and Biophysics, 703, Article ID: 108871. [Google Scholar] [CrossRef] [PubMed]
|
|
[59]
|
Wang, Q., Wang, G.T. and Lu, W.H. (2021) MiR-155 Inhibits Malignant Biological Behavior of Human Liver Cancer Cells by Regulating SRPK1. Technology in Cancer Research & Treatment, 20. [Google Scholar] [CrossRef] [PubMed]
|
|
[60]
|
Jin, W., Liang, Y., Li, S., et al. (2021) MiR-513b-5p Represses Autophagy during the Malignant Progression of Hepatocellular Carcinoma by Targeting PIK3R3. Aging, 13, 16072-16087. [Google Scholar] [CrossRef] [PubMed]
|
|
[61]
|
Chi, Y., Gong, Z., Xin, H., et al. (2022) MicroRNA-206 Prevents Hepatocellular Carcinoma Growth and Metastasis via Down-Regulating CREB5 and Inhibiting the PI3K/AKT Signaling Pathway. Cell Cycle, 21, 2651-2663. [Google Scholar] [CrossRef] [PubMed]
|
|
[62]
|
Nie, X., Liu, H., Wei, X., et al. (2021) MiRNA-382-5p Suppresses the Expression of Farnesoid X Receptor to Promote Progression of Liver Cancer. er Management and Research, 13, 8025-8035. [Google Scholar] [CrossRef]
|
|
[63]
|
El-Mezayen, H., Yamamura, K., Yusa, T., et al. (2021) MicroRNA-25 Exerts an Oncogenic Function by Regulating the Ubiquitin Ligase Fbxw7 in Hepatocellular Carcinoma. Annals of Surgical Oncology, 28, 7973-7982. [Google Scholar] [CrossRef] [PubMed]
|
|
[64]
|
Yu, Z., Chen, T., Mo, H., et al. (2020) BRD8, Which Is Negatively Regulated by MiR-876-3p, Promotes the Proliferation and Apoptosis Resistance of Hepatocellular Carcinoma Cells via KAT5. Archives of Biochemistry and Biophysics, 693, Article ID: 108550. [Google Scholar] [CrossRef] [PubMed]
|
|
[65]
|
Gao, Y., Zhang, S.G., Wang, Z.H., et al. (2017) Down-Regulation of MiR-342-3p in Hepatocellular Carcinoma Tissues and Its Prognostic Significance. European Review for Medical and Pharmacological Sciences, 21, 2098-2102.
|
|
[66]
|
Komoll, R.M., Hu, Q., Olarewaju, O., et al. (2021) MicroRNA-342-3p Is A Potent Tumour Suppressor in Hepatocellular Carcinoma. Journal of Hepatology, 74, 122-134. [Google Scholar] [CrossRef] [PubMed]
|
|
[67]
|
Xu, C., Sun, W., Liu, J., et al. (2022) MiR-342-3p Inhibits LCSC Oncogenicity and Cell Stemness through HDAC7/PTEN Axis. Inflammation Research, 71, 107-117. [Google Scholar] [CrossRef] [PubMed]
|
|
[68]
|
Fu, Y., Mackowiak, B., Feng, D., et al. (2023) MicroRNA-223 Attenuates Hepatocarcinogenesis by Blocking Hypoxia-Driven Angiogenesis and Immunosuppression. Gut, 72, 1942-1958. [Google Scholar] [CrossRef] [PubMed]
|
|
[69]
|
Zou, S., Chen, S., Rao, G., et al. (2024) Extrachromosomal Circular MiR-17-92 Amplicon Promotes HCC. Hepatology, 79, 79-95. [Google Scholar] [CrossRef]
|
|
[70]
|
Huang, H.Q., Chen, G., Xiong, D.D., et al. (2021) Down-Regulation of MicroRNA-125b-2-3p Is a Risk Factor for a Poor Prognosis in Hepatocellular Carcinoma. Bioengineered, 12, 1627-1641. [Google Scholar] [CrossRef] [PubMed]
|
|
[71]
|
Cong, S., Liu, Y., Li, Y., et al. (2021) MiR-571 Affects the Development and Progression of Liver Fibrosis by Regulating the Notch3 Pathway. Scientific Reports, 11, Article No. 21854. [Google Scholar] [CrossRef] [PubMed]
|
|
[72]
|
Yugawa, K., Yoshizumi, T., Mano, Y., et al. (2021) Cancer-Associated Fibroblasts Promote Hepatocellular Carcinoma Progression through Downregulation of Exosomal MiR-150-3p. European Journal of Surgical Oncology, 47, 384-393. [Google Scholar] [CrossRef] [PubMed]
|
|
[73]
|
Chi, X., Jiang, Y., Chen, Y., et al. (2021) Upregulation of MicroRNA MiR-652-3p Is a Prognostic Risk Factor for Hepatocellular Carcinoma and Regulates Cell Proliferation, Migration, and Invasion. Bioengineered, 12, 7519-7528. [Google Scholar] [CrossRef] [PubMed]
|
|
[74]
|
Li, Z., Wu, L., Tan, W., et al. (2021) MiR-20b-5p Promotes Hepatocellular Carcinoma Cell Proliferation, Migration and Invasion by Down-Regulating CPEB3. Annals of Hepatology, 23, Article ID: 100345. [Google Scholar] [CrossRef] [PubMed]
|
|
[75]
|
Yokota, Y., Noda, T., Okumura, Y., et al. (2021) Serum Exosomal MiR-638 Is a Prognostic Marker of HCC via Downregulation of VE-Cadherin and ZO-1 of Endothelial Cells. Cancer Science, 112, 1275-1288. [Google Scholar] [CrossRef] [PubMed]
|